Overall rank by patents
#27,316
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Shanghai holds 10 US patents across 11 technology areas, rank #27,316 of 50,000 tracked assignees.
Shanghai Junshi Biosciences Co., Ltd has been granted 10 US utility patents between 2017 and 2025, placing Shanghai Junshi Biosciences Co., Ltd at rank #27,316 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.0 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Shanghai Junshi Biosciences Co., Ltd is one of the more focused assignees in the PatentsView dataset. By volume, Shanghai sits between Seungjin IND. Co., Ltd (10 patents, rank #27,312) and Shanghai Tobacco Group Co., Ltd (10 patents, rank #27,320) - the closest US assignees by grant volume. The composite Innovation Score of 49.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Shanghai Junshi Biosciences Co., Ltd's 16.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Shanghai Junshi Biosciences Co., Ltd against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SEUNGJIN IND. CO., LTD
10 patents
SFC Global Supply Chain, Inc.
10 patents
SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
10 patents
SHANGHAI AIR-PAQ COMPOSITE MATERIAL CO., LTD.
10 patents
SHANGHAI LINGHUO TRADING CO., LTD.
10 patents
SHANGHAI MARITIME UNIVERSITY
10 patents
SHANGHAI NUCLEAR ENGINEERING RESEARCH & DESIGN INSTITUTE CO., LTD.
10 patents
SHANGHAI TOBACCO GROUP CO., LTD
10 patents
SHANGHAI JUNSHI BIOSCIENCES CO., LTD
10 patents
What this shows Shanghai holds 10 patents at rank #27,316, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,316 in granted patent volume.
Other assignees with the most granted patents in Shanghai's primary technology class.
Shanghai's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
50 Top 14% higher than 86% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 10.0% |
| 2018 | 1 | 10.0% |
| 2020 | 1 | 10.0% |
| 2022 | 2 | 20.0% |
| 2023 | 1 | 10.0% |
| 2024 | 2 | 20.0% |
| 2025 | 2 | 20.0% |
Top 11 of 11 technology areas
Overall rank by patents
#27,316
Across all tracked assignees
49.6 out of 100
How to use this portfolio
Shanghai's 10 grants land it in the top 14% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.